Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of the FARAFLEX Mapping and Pulsed Field Ablation (PFA) System in the Treatment of Persistent Atrial Fibrillation

NCT06510556 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT06510556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06510556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of the FARAFLEX Mapping and Pulsed Field Ablation (PFA) System in the Treatment of Persistent Atrial Fibrillation
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Recruiting
Start date
February 17, 2025
Completion date
September 15, 2027
Enrollment
250 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, paroxysmal af, persistent atrial fibrillation